---
title: Mucus Hypersecretion in Respiratory Disease
description: Learn how we tested novel biologicals to determine effects on mucin secretion in airway epithelial cells for a leading biopharmaceutical customer.
image: https://info.bioivt.com/hubfs/Images/DS_Resp%20Case%20Study%20Landing%20Page-04.jpg
---

*Questions? We’re here to help:*

[+1 516-483-1196](tel:+1%20516-483-1196) or [+44 1444 707333](tel:+44%201444%20707333)

[Contact Us](https://www.bioivt.com/about/contact-us)

[![BioIVT-Logo-Tag-New](https://info.bioivt.com/hubfs/BioIVT-Logo-Tag-New.png)](https://bioivt.com)

- [BioIVT.com](https://bioivt.com/)

Search

[View My Quote](https://www.bioivt.com/?showQuoteOverlay=true)

# Case Study: Mucus Hypersecretion in Respiratory Disease

![BioIVT_Case Study_Mucus Sec](https://info.bioivt.com/hs-fs/hubfs/BioIVT_Case%20Study_Mucus%20Sec.jpg?width=305&height=305&name=BioIVT_Case%20Study_Mucus%20Sec.jpg)Read how we tested novel biologicals to determine effects on mucin secretion in airway epithelial cells for a leading biopharmaceutical customer.

You'll learn how:

- A functional 3D Air-Liquid Interface (ALI) model provides actionable data for drug development scientists to make go/no-go decisions
- Custom cell isolation allows for development of novel, fit-for-purpose models based on clients need
- The ability to combine molecular/genomic approaches with 2D/3D models allows both the study of therapeutic effect, disposition and safety with functional assays

Download your copy today!

### Download Now

Copyright © 2026 BioIVT. All Rights Reserved. [Contact Us](https://www.bioivt.com/about/contact-us/).